PBSS-San Francisco: Small-Molecule Formulation for Discovery & Early Development
PBSS Small Molecule Formulation for Discovery and Early Development Workshop in Foster City is a specialized event that focuses on the formulation challenges and strategies for small molecule drug development, particularly in early stages of discovery and preclinical development. This workshop brings together experts to discuss best practices, emerging technologies, and key issues that impact the efficacy, stability, and delivery of small molecule drugs.
Date: January 22, 2025
Location: Foster City, CA
Booth: Catalent
JOIN US!
Stop by our booth to learn about the latest advancements in early phase development. Don’t miss out on our featured talk covering a key industry topic – Navigating the Path to Phase 1: Leveraging Developability Assessments for Formulation Success at 3:00 pm.
Complete the form to schedule a meeting with Catalent at the PBSS San Francisco Bay.
WORKSHOP PRESENTATION
Title: Navigating the Path to Phase 1: Leveraging Developability Assessments for Formulation Success
Date: January 22, 2025
Time: 2:50 pm
SPEAKER
Nathan Bennette
Director, Scientific Advisory
Catalent
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
